2015. Randomized Controlled, Double Blind Trial of Topical Twice Weekly Fluti
Rubio et al. World Allergy Organization Journal 2013, 6(Suppl 1):P102 http://www.waojournal.org/content/6/S1/P102 MEETINGABSTRACT Open Access Allergic diseases of the skin and drug allergies – 2015. Randomized controlled, double blind trial of topical twice weekly fluticasone propionate maintenance treatment to reduce risk of relapse in mild or moderate atopic dermatitis in children Elena Rubio1*, Inocencia Martinez-Mir2, Francisco J Morales-Olivas3, Antonio Martorell-Aragonés4, Vicente Palop Larrea5, Alejandro Bernalte Sesé6, Juan C Cerdá Mir4, Pedro Polo Martín7, Isabel Febrer8, Laura Aranda Grau9, Inmaculada Llosa Cortes10, María José Tejedor Sanz11, Juan C Juliá Benito12, Teresa Álvarez De Laviada13, María Victoria Planelles Cantarino14, Esther Apolinar Valiente15, Mercedes Loriente Tur16, Antonio M Abella Bazataqui17, Irene Álvarez Gonzalez18, Cristina Morales-Carpi19, Maria Enrriqueta Burches Greu20, Ana B Ferrer Bautista14, Raúl Felix Toledo4, Dolores Marmeneu Laguia16, Victoria E Garcia-Martinez16, María Antonia Beltran Marques15, María Begoña Rodriguez Gracia21, Inocencia Martinez-Mir2 From 2nd WAO International Scientific Conference (WISC 2012) Hyderabad, India. 6-9 December 2012 Background success (SCORAD<5or≥75% initial SCORAD) entered One of the most troublesome features of atopic dermatitis the Double-blind Maintenance Phase (DMP). They were (AD) is its chronic relapsing nature. The long-term randomly allocated to receive FP or vehicle twice weekly efficacy and potential of corticosteroids to reduce or pre- on consecutive days for 16 weeks. The primary study vent relapses have only partially been addressed, especially endpoint was relapse rate of AD, time to relapse and in children. This study was designed to compare an inter- severity of disease were also studied.
[Show full text]